logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Douglas Yee

University of Minnesota
H指数:83
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signaling

肿瘤特异性lncRNA IGF1R-AS1跨调控与致癌性MYC信号通路相关的染色质相互作用

Nature Communications
IF15.7
2026-03-190
OAAI
Yongyong Yang; Ting-You Wang; Joshua Fry; Yingming Li; Qingshu Meng; Qingxiang Guo; Nathan E. Patchen; Kyle H. White; Abhirami Ramakrishnan; Yanan Ren; Qianru Li; Xingxing Zhang; Taufeeque Ali; Courtney Dawes; Stamatina Fragkogianni; Parker Irvin; Sk Kayum Alam; Luke H. Hoeppner; Xihong Zhang; Douglas Yee; Adam B. Weiner; Edward M. Schaeffer; Yang Liu; Xiaoyang Zhang; Scott M. Dehm; Qi Cao; Rendong Yang
RISE UP for breast cancer 2024: conference highlights & takeaways
Breast Cancer Research and Treatment
IF3
2026-01-060
OAAI
Taylor Glatt; Katherine Leggat-Barr; Nandini Seth; Diane Heditsian; Laura van ’t Veer; Lajos Pusztai; Elissa Price; Nola Hylton; Silvia Formenti; Hope Rugo; Laura Fejerman; Adetunji T. Toriola; Carol Fabian; Andrea De Censi; Daniel Grossman; Olufunmilayo Olopade; Andrea Jackson; Sara Horton; Kim Rhoads; Carol Lange; Virginia Borges; Elizabeth Garner; Judy Garber; Douglas Yee; Laura Esserman
ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial

ASO视觉摘要：新辅助化疗后至手术时间对乳腺癌结局的影响：一项基于I-SPY 2临床试验入组患者的研究

Annals of Surgical Oncology
IF3.5
2025-08-290
PRE
Julie Van Hassel; Katrina Dimitroff; Christina Yau; Rita Mukhtar; Judy C. Boughey; Velle Ladores; Marissa M. Howard-McNatt; Nora Jaskowiak; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Laura van’t Veer; Hope Rugo; Laura J. Esserman; Rebecca Shatsky; Claudine Isaacs; Henry Kuerer; Anne M. Wallace; Nicolas Prionas; Jennifer Tseng; Chantal R. Reyna; Neil Taunk; Susan Kesmodel; Marie C. Lee; Jana Fox; Mara A. Piltin; Julia Tchou; Cletus A. Arciero; Lauren M. Postlewait; Candice Sauder; Roshni Rao
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial

新辅助化疗后手术时间对乳腺癌结局的影响：一项基于I-SPY 2临床试验入组患者的研究

Annals of Surgical Oncology
IF3.5
2025-08-230
PRE
Julie Van Hassel; Katrina Dimitroff; Christina Yau; Rita Mukhtar; Judy C. Boughey; Velle Ladores; Marissa M. Howard-McNatt; Nora Jaskowiak; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Laura van’t Veer; Hope Rugo; Laura J. Esserman; Rebecca Shatsky; Claudine Isaacs; Henry Kuerer; Anne M. Wallace; Nicolas Prionas; Jennifer Tseng; Chantal R. Reyna; Neil Taunk; Susan Kesmodel; Marie C. Lee; Jana Fox; Mara A. Piltin; Julia Tchou; Cletus A. Arciero; Lauren M. Postlewait; Candice Sauder; Roshni Rao
ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial

ASO视觉摘要：新辅助化疗对浸润性小叶乳腺癌手术结果及淋巴结阴性转化率的影响：根据I-SPY2临床试验中分子高风险肿瘤的组织学亚型进行分析

Annals of Surgical Oncology
IF3.5
2025-08-230
PRE
Rita A. Mukhtar; Katrina Dimitroff; Christina Yau; A. Jo Chien; Eileen P. Connolly; Marissa Howard-McNatt; Roshni Rao; Velle Ladores; Mehra Golshan; Candice A. Sauder; Kamran Ahmed; Rachael Lancaster; Jana Fox; Lily Gutnik; M. Catherine Lee; Julia Tchou; Nicolas Prionas; Cletus A. Arciero; Chantal Reyna; Henry Kuerer; Kayla Switalla; Neil Taunk; Todd M. Tuttle; Meena S. Moran; Lauren M. Postlewait; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Hope S. Rugo; Rebecca Shatsky; Claudine Isaacs; Laura J. Esserman; Laura van ‘t Veer; Judy C. Boughey
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial

新辅助化疗对浸润性小叶乳腺癌手术结果及淋巴结阴性转化影响的评估：基于I-SPY2临床试验中按组织学亚型分析分子高风险肿瘤

Annals of Surgical Oncology
IF3.5
2025-07-240
OA
Rita A. Mukhtar; Katrina Dimitroff; Christina Yau; A. Jo Chien; Eileen P. Connolly; Marissa Howard-McNatt; Roshni Rao; Velle Ladores; Mehra Golshan; Candice A. Sauder; Kamran Ahmed; Rachael Lancaster; Jana Fox; Lily Gutnik; M. Catherine Lee; Julia Tchou; Nicolas Prionas; Cletus A. Arciero; Chantal Reyna; Henry Kuerer; Kayla Switalla; Neil Taunk; Todd M. Tuttle; Meena S. Moran; Lauren M. Postlewait; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Hope S. Rugo; Rebecca Shatsky; Claudine Isaacs; Laura J. Esserman; Laura van’t Veer; Judy C. Boughey
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial

在多中心新辅助I-SPY2试验中，基于自我识别种族的腋窝手术管理差异

Annals of Surgical Oncology
IF3.5
2025-07-230
OA
Mandeep Kaur; Katrina Dimitroff; Judy C. Boughey; Laura J. Esserman; Christina Yau; Julia Tchou; Astrid Quirarte; Marie Catherine Lee; Marissa M. Howard-McNatt; Kayla Switalla; Henry Kuerer; Candice Sauder; Lauren M. Postlewait; Cletus Arciero; Roshni Rao; Anne Wallace; Chantal Reyna; Kamran Ahmed; Lily Gutnik; Neil Taunk; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola M. Hylton; W. Fraser Symmans; Hope S. Rugo; Rebecca A. Shatsky; Claudine Isaacs; Sonali Rudra; Paula Pohlmann; Cheryl Ewing; Jasmine Wong; Michael Alvarado; Nora Jaskowiak; Nicolas Prionas; Mehra Golshan; Mara A. Piltin; Olufunmilayo I. Olopade; Rita A. Mukhtar
Pathologic complete response (pCR) rates for patients with HRD/HER2L high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial

在I-SPY2临床试验中，根据临床和分子特征，HRD/HER2L高风险早期乳腺癌（EBC）患者的病理完全缓解（pCR）率。

ANNALS OF ONCOLOGY
IF65.4
2025-02-012
PRE
Huppert, L. A.; Wolf, D.; Yau, C.; Brown-Swigart, L.; Hirst, G. L.; Isaacs, C.; Pusztai, L.; Pohlmann, P. R.; Demichele, A.; Shatsky, R.; Yee, D.; Thomas, A.; Nanda, R.; Perlmutter, J.; Heditsian, D.; Hylton, N.; Symmans, F.; van't Veer, L. J.; Esserman, L.; Rugo, H. S.
Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer
BREAST CANCER RESEARCH AND TREATMENT
IF3
2024-12-030
OAAI
Rugo, Hope S.; Campbell, Mike; Yau, Christina; Jo Chien, A.; Wallace, Anne M.; Isaacs, Claudine; Boughey, Judy C.; Han, Hyo S.; Buxton, Meredith; Clennell, Julia L.; Asare, Smita M.; Steeg, Katherine; Wilson, Amy; Singhrao, Ruby; Matthews, Jeffrey B.; Perlmutter, Jane; Fraser Symmans, W.; Hylton, Nola M.; Demichele, Angela M.; Yee, Douglas; Van't Veer, Laura J.; Berry, Donald A.; Esserman, Laura J.
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer
CELL REPORTS MEDICINE
IF10.6
2024-11-010
OAAI
Campbell, Michael J.; Wolf, Denise M.; Yau, Christina; Brown-Swigart, Lamorna; Wulfkuhle, Julie; Gallagher, Isela R.; Zhu, Zelos; Bolen, Jennifer; Vandenberg, Scott; Hoyt, Clifford; Mori, Hidetoshi; Borowsky, Alexander; Sit, Laura; Perlmutter, Jane; Asare, Smita M.; Nanda, Rita; Liu, Minetta C.; Yee, Douglas; Demichele, Angela M.; Hylton, Nola M.; Pusztai, Lajos; Berry, Donald A.; Hirst, Gillian L.; Petricoin, Emanuel F.; van't Veer, Laura; Esserman, Laura
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Datopotamab-deruxtecan治疗早期乳腺癌: 序贯多重分配随机I-SPY2.2 2期试验

NATURE MEDICINE
IF50
2024-09-141
PRE
Khoury, Katia; Meisel, Jane L.; Yau, Christina; Rugo, Hope S.; Nanda, Rita; Davidian, Marie; Tsiatis, Butch; Chien, A. Jo; Wallace, Anne M.; Arora, Mili; Rozenblit, Mariya; Hershman, Dawn L.; Zimmer, Alexandra; Clark, Amy S.; Beckwith, Heather; Elias, Anthony D.; Stringer-Reasor, Erica; Boughey, Judy C.; Nangia, Chaitali; Vaklavas, Christos; Omene, Coral; Albain, Kathy S.; Kalinsky, Kevin M.; Isaacs, Claudine; Tseng, Jennifer; Torres, Evanthia T. Roussos; Thomas, Brittani; Thomas, Alexandra; Sanford, Amy; Balassanian, Ronald; Ewing, Cheryl; Yeung, Kay; Sauder, Candice; Sanft, Tara; Pusztai, Lajos; Trivedi, Meghna S.; Outhaythip, Ashton; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Beedle, Carolyn; Perlmutter, Jane; Pohlmann, Paula; Shatsky, Rebecca A.; Demichele, Angela; Yee, Douglas; van't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Datopotamab-deruxtecan联合durvalumab治疗早期乳腺癌: 序贯多重分配随机I-SPY2.2 2期试验

NATURE MEDICINE
IF50
2024-09-144
PRE
Shatsky, Rebecca A.; Trivedi, Meghna S.; Yau, Christina; Nanda, Rita; Rugo, Hope S.; Davidian, Marie; Tsiatis, Butch; Wallace, Anne M.; Chien, A. Jo; Stringer-Reasor, Erica; Boughey, Judy C.; Omene, Coral; Rozenblit, Mariya; Kalinsky, Kevin; Elias, Anthony D.; Vaklavas, Christos; Beckwith, Heather; Williams, Nicole; Arora, Mili; Nangia, Chaitali; Torres, Evanthia T. Roussos; Thomas, Brittani; Albain, Kathy S.; Clark, Amy S.; Falkson, Carla; Hershman, Dawn L.; Isaacs, Claudine; Thomas, Alexandra; Tseng, Jennifer; Sanford, Amy; Yeung, Kay; Boles, Sarah; Chen, Yunni Yi; Huppert, Laura; Jahan, Nusrat; Parker, Catherine; Giridhar, Karthik; Howard, Frederick M.; Blackwood, M. Michele; Sanft, Tara; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Heditsian, Diane; Lestage, Barbara; Perlmutter, Jane; Pohlmann, Paula; Demichele, Angela; Yee, Douglas; van 't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.

研究方向

暂未获取到该数据
C
Christina Yau
H 指数:92论文数:571被引数:7.9万
L
Laura J. Esserman
H 指数:89论文数:990被引数:3.3万
A
Angela DeMichele
H 指数:89论文数:736被引数:2.8万
C
Claudine Isaacs
H 指数:97论文数:751被引数:3.7万
N
Nola M. Hylton
H 指数:62论文数:375被引数:1.4万
J
Jane Perlmutter
H 指数:41论文数:205被引数:1.7万
J
Judy C. Boughey
H 指数:80论文数:838被引数:2.3万
W
W. Fraser Symmans
H 指数:105论文数:915被引数:4.8万
R
Rita Nanda
H 指数:56论文数:548被引数:1.6万
G
Gillian L. Hirst
H 指数:29论文数:279被引数:5,591